(CNN) In a highly anticipated announcement, Pfizer said on Monday a Phase 2/3 trial showed its Covid-19 vaccine was safe and generated a "robust" antibody response in children ages 5 to 11. "Further, the COVID-19 vaccine was well tolerated, with side effects generally comparable to those observed in participants 16 to 25 years of age," the company said. Calls for a Covid-19 vaccine for younger children have grown louder in recent months as cases surged among children. Currently, about 85% of the US population is eligible to receive a Covid-19 vaccine. But the 5 to 11 age group represents about 9% of the total United States population, which would bump it up to 94%.

Source: CNN September 20, 2021 10:45 UTC